PATENT CLAIM ANALYSIS

Application Number: 16132616
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "404000"]

Abstract:
Invented is a method of treating cancer or a pre-cancerous syndrome in a mammal, including a human, in need thereof which comprises the administration of an effective amount of a non-peptide thrombopoietin (TPO) receptor agonist to such mammal, suitably a human.

Claim (Index 2):
The method according to  claim 1  wherein the mammal is a human.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 97.0
- Lexical Diversity: 1.34286
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13487512', '11620260', '13318550', '11558071', '10296688']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7702517142397338
- 35 USC 102 Novelty (BERT): 0.5874724214511817
- Combined Prediction Score: 0.7519737849608786
- Mean Citation Score: 355.29939
- Max Citation Score: 478.00198
- Similarity Product: 432.288290619936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test